Table of content:

1 Study Coverage

• 1.1 Pets NSAIDs Product Introduction
• 1.2 Global Pets NSAIDs Outlook 2017 VS 2022 VS 2028
• 1.2.1 Global Pets NSAIDs Sales in US$ Million for the Year 2017-2028

1.2.2 Global Pets NSAIDs Sales in Volume for the Year 2017-2028

1.3 United States Pets NSAIDs Outlook 2017 VS 2022 VS 2028

1.3.1 United States Pets NSAIDs Sales in US$ Million for the Year 2017-2028

1.3.2 United States Pets NSAIDs Sales in Volume for the Year 2017-2028

1.4 Pets NSAIDs Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.4.1 The Market Share of United States Pets NSAIDs in Global, 2017 VS 2022 VS 2028

1.4.2 The Growth Rate of Pets NSAIDs Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.5 Pets NSAIDs Market Dynamics

1.5.1 Pets NSAIDs Industry Trends

1.5.2 Pets NSAIDs Market Drivers

1.5.3 Pets NSAIDs Market Challenges

1.5.4 Pets NSAIDs Market Restraints

1.6 Study Objectives

1.7 Years Considered

2 Market by Type

• 2.1 Pets NSAIDs Market Segment by Type
• 2.1.1 Injection Type

2.1.2 Oral Type

2.1.3 Others

2.2 Global Pets NSAIDs Market Size by Type

2.2.1 Global Pets NSAIDs Sales in Value, by Type (2017, 2022 & 2028)

2.2.2 Global Pets NSAIDs Sales in Volume, by Type (2017, 2022 & 2028)

2.2.3 Global Pets NSAIDs Average Selling Price (ASP) by Type (2017, 2022 & 2028)

2.3 United States Pets NSAIDs Market Size by Type

2.3.1 United States Pets NSAIDs Sales in Value, by Type (2017, 2022 & 2028)

2.3.2 United States Pets NSAIDs Sales in Volume, by Type (2017, 2022 & 2028)

2.3.3 United States Pets NSAIDs Average Selling Price (ASP) by Type (2017, 2022 & 2028)

3 Market by Application

• 3.1 Pets NSAIDs Market Segment by Application
• 3.1.1 Pet Hospital

3.1.2 Pet Shop

3.1.3 Household Use

3.2 Global Pets NSAIDs Market Size by Application

3.2.1 Global Pets NSAIDs Sales in Value, by Application (2017, 2022 & 2028)

3.2.2 Global Pets NSAIDs Sales in Volume, by Application (2017, 2022 & 2028)

3.3.3 Global Pets NSAIDs Average Selling Price (ASP) by Application (2017, 2022 & 2028)

3.3 United States Pets NSAIDs Market Size by Application

3.3.1 United States Pets NSAIDs Sales in Value, by Application (2017, 2022 & 2028)

3.3.2 United States Pets NSAIDs Sales in Volume, by Application (2017, 2022 & 2028)

3.3.3 United States Pets NSAIDs Average Selling Price (ASP) by Application (2017, 2022 & 2028)

4 Global Pets NSAIDs Competitor Landscape by Company

• 4.1 Global Pets NSAIDs Market Size by Company
• 4.1.1 Top Global Pets NSAIDs Manufacturers Ranked by Revenue (2021)

4.1.2 Global Pets NSAIDs Revenue by Manufacturer (2017-2022)

4.1.3 Global Pets NSAIDs Sales by Manufacturer (2017-2022)

4.1.4 Global Pets NSAIDs Price by Manufacturer (2017-2022)

4.2 Global Pets NSAIDs Concentration Ratio (CR)

4.2.1 Pets NSAIDs Market Concentration Ratio (CR) (2017-2022)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pets NSAIDs in 2021

4.2.3 Global Pets NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Pets NSAIDs Manufacturing Base Distribution, Product Type

4.3.1 Global Pets NSAIDs Manufacturers, Headquarters and Distribution of Producing Region

4.3.2 Manufacturers Pets NSAIDs Product Type

4.3.3 Date of International Manufacturers Enter into Pets NSAIDs Market

4.4 Manufacturers Mergers & Acquisitions, Expansion Plans

4.5 United States Pets NSAIDs Market Size by Company

4.5.1 Top Pets NSAIDs Players in United States, Ranked by Revenue (2021)

4.5.2 United States Pets NSAIDs Revenue by Players (2020, 2021 & 2022)

4.5.3 United States Pets NSAIDs Sales by Players (2020, 2021 & 2022)

5 Global Pets NSAIDs Market Size by Region

• 5.1 Global Pets NSAIDs Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Pets NSAIDs Market Size in Volume by Region (2017-2028)
• 5.2.1 Global Pets NSAIDs Sales in Volume by Region: 2017-2022

5.2.2 Global Pets NSAIDs Sales in Volume Forecast by Region (2023-2028)

5.3 Global Pets NSAIDs Market Size in Value by Region (2017-2028)

5.3.1 Global Pets NSAIDs Sales in Value by Region: 2017-2022

5.3.2 Global Pets NSAIDs Sales in Value by Region: 2023-2028

6 Segment in Region Level & Country Level

• 6.1 North America
• 6.1.1 North America Pets NSAIDs Market Size YoY Growth 2017-2028

6.1.2 North America Pets NSAIDs Market Facts & Figures by Country (2017, 2022 & 2028)

6.1.3 United States

6.1.4 Canada

6.2 Asia-Pacific

6.2.1 Asia-Pacific Pets NSAIDs Market Size YoY Growth 2017-2028

6.2.2 Asia-Pacific Pets NSAIDs Market Facts & Figures by Region (2017, 2022 & 2028)

6.2.3 China

6.2.4 Japan

6.2.5 South Korea

6.2.6 India

6.2.7 Australia

6.2.8 China Taiwan

6.2.9 Indonesia

6.2.10 Thailand

6.2.11 Malaysia

6.3 Europe

6.3.1 Europe Pets NSAIDs Market Size YoY Growth 2017-2028

6.3.2 Europe Pets NSAIDs Market Facts & Figures by Country (2017, 2022 & 2028)

6.3.3 Germany

6.3.4 France

6.3.5 U.K.

6.3.6 Italy

6.3.7 Russia

6.4 Latin America

6.4.1 Latin America Pets NSAIDs Market Size YoY Growth 2017-2028

6.4.2 Latin America Pets NSAIDs Market Facts & Figures by Country (2017, 2022 & 2028)

6.4.3 Mexico

6.4.4 Brazil

6.4.5 Argentina

6.4.6 Colombia

6.5 Middle East and Africa

6.5.1 Middle East and Africa Pets NSAIDs Market Size YoY Growth 2017-2028

6.5.2 Middle East and Africa Pets NSAIDs Market Facts & Figures by Country (2017, 2022 & 2028)

6.5.3 Turkey

6.5.4 Saudi Arabia

6.5.5 UAE

7 Company Profiles

• 7.1 Merck
• 7.1.1 Merck Corporation Information

7.1.2 Merck Description and Business Overview

7.1.3 Merck Pets NSAIDs Sales, Revenue and Gross Margin (2017-2022)

7.1.4 Merck Pets NSAIDs Products Offered

7.1.5 Merck Recent Development

7.2 Bayer

7.2.1 Bayer Corporation Information

7.2.2 Bayer Description and Business Overview

7.2.3 Bayer Pets NSAIDs Sales, Revenue and Gross Margin (2017-2022)

7.2.4 Bayer Pets NSAIDs Products Offered

7.2.5 Bayer Recent Development

7.3 JandJ

7.3.1 JandJ Corporation Information

7.3.2 JandJ Description and Business Overview

7.3.3 JandJ Pets NSAIDs Sales, Revenue and Gross Margin (2017-2022)

7.3.4 JandJ Pets NSAIDs Products Offered

7.3.5 JandJ Recent Development

7.4 GSK

7.4.1 GSK Corporation Information

7.4.2 GSK Description and Business Overview

7.4.3 GSK Pets NSAIDs Sales, Revenue and Gross Margin (2017-2022)

7.4.4 GSK Pets NSAIDs Products Offered

7.4.5 GSK Recent Development

7.5 Septodont

7.5.1 Septodont Corporation Information

7.5.2 Septodont Description and Business Overview

7.5.3 Septodont Pets NSAIDs Sales, Revenue and Gross Margin (2017-2022)

7.5.4 Septodont Pets NSAIDs Products Offered

7.5.5 Septodont Recent Development

7.6 Roche

7.6.1 Roche Corporation Information

7.6.2 Roche Description and Business Overview

7.6.3 Roche Pets NSAIDs Sales, Revenue and Gross Margin (2017-2022)

7.6.4 Roche Pets NSAIDs Products Offered

7.6.5 Roche Recent Development

7.7 PerioChip

7.7.1 PerioChip Corporation Information

7.7.2 PerioChip Description and Business Overview

7.7.3 PerioChip Pets NSAIDs Sales, Revenue and Gross Margin (2017-2022)

7.7.4 PerioChip Pets NSAIDs Products Offered

7.7.5 PerioChip Recent Development

7.8 Mobic

7.8.1 Mobic Corporation Information

7.8.2 Mobic Description and Business Overview

7.8.3 Mobic Pets NSAIDs Sales, Revenue and Gross Margin (2017-2022)

7.8.4 Mobic Pets NSAIDs Products Offered

7.8.5 Mobic Recent Development

7.9 Rimadyl

7.9.1 Rimadyl Corporation Information

7.9.2 Rimadyl Description and Business Overview

7.9.3 Rimadyl Pets NSAIDs Sales, Revenue and Gross Margin (2017-2022)

7.9.4 Rimadyl Pets NSAIDs Products Offered

7.9.5 Rimadyl Recent Development

7.10 Vetprofen

7.10.1 Vetprofen Corporation Information

7.10.2 Vetprofen Description and Business Overview

7.10.3 Vetprofen Pets NSAIDs Sales, Revenue and Gross Margin (2017-2022)

7.10.4 Vetprofen Pets NSAIDs Products Offered

7.10.5 Vetprofen Recent Development

7.11 Novox

7.11.1 Novox Corporation Information

7.11.2 Novox Description and Business Overview

7.11.3 Novox Pets NSAIDs Sales, Revenue and Gross Margin (2017-2022)

7.11.4 Novox Pets NSAIDs Products Offered

7.11.5 Novox Recent Development

8 Industry Chain and Sales Channels Analysis

• 8.1 Pets NSAIDs Industry Chain Analysis
• 8.2 Pets NSAIDs Key Raw Materials
• 8.2.1 Key Raw Materials

8.2.2 Pets NSAIDs Distributors

8.3 Pets NSAIDs Production Mode & Process

8.4 Pets NSAIDs Sales and Marketing

8.4.1 Pets NSAIDs Sales Channels

8.4.2 Pets NSAIDs Distributors

8.5 Pets NSAIDs Customers

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
• 10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

Description:
Market Analysis and Insights: Global and United States Pets NSAIDs Market

This report focuses on global and United States Pets NSAIDs market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Pets NSAIDs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Injection Type accounting for % of the Pets NSAIDs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Pet Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Pets NSAIDs market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Pets NSAIDs Scope and Market Size

Pets NSAIDs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Pets NSAIDs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Pets NSAIDs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Pets NSAIDs market is segmented into

Injection Type

Oral Type

Others

Segment by Application, the Pets NSAIDs market is segmented into

Pet Hospital

Pet Shop

Household Use

Regional and Country-level Analysis

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Landscape and Pets NSAIDs Market Share Analysis

Pets NSAIDs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Pets NSAIDs business, the date to enter into the Pets NSAIDs market, Pets NSAIDs product introduction, recent developments, etc.

The major vendors covered:

Merck

Bayer

JandJ

GSK

Septodont

Roche

PerioChip

Mobic

Rimadyl

Vetprofen

Novox